NASDAQ:CERE - Ceres Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
Previous Close$0.3970
Today's Range$0.3970 - $0.3970
52-Week Range$0.16 - $4.80
VolumeN/A
Average Volume848,868 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Ceres, Inc. is an agricultural biotechnology company that develops and markets seeds and traits to produce crops for feed, forages, sugar and other markets. The Company uses a combination of plant breeding, biotechnology and bioinformatics to develop seed products and biotechnology traits. Its Forage sorghum seeds are used for growing feed for livestock, including dairy and beef cattle. Its technology platforms have application across various end markets, including food, feed, fiber and fuel. It has developed bioinformatics software, Persephone, to deal with the data generated in plant genomics. Its Persephone enables storage and access to datasets, as well as data visualizations to view genetic data from public sources and databases. It markets its seed products under the name Blade. Its customers include dairies and livestock producers, agri-industrial facilities, individual growers and grower cooperatives. It deploys a range of research and development methods and tools.

Receive CERE News and Ratings via Email

Sign-up to receive the latest news and ratings for CERE and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryCoal & Consumable Fuels
SectorN/A
Current SymbolNASDAQ:CERE
CUSIP15677310
Phone+1-805-3766500

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Ceres (NASDAQ:CERE) Frequently Asked Questions

What is Ceres' stock symbol?

Ceres trades on the NASDAQ under the ticker symbol "CERE."

How were Ceres' earnings last quarter?

Ceres Inc (NASDAQ:CERE) announced its quarterly earnings data on Thursday, April, 14th. The biotechnology company reported ($0.09) earnings per share for the quarter. The biotechnology company earned $0.35 million during the quarter, compared to analysts' expectations of $7.60 million. View Ceres' Earnings History.

Has Ceres been receiving favorable news coverage?

Headlines about CERE stock have been trending somewhat negative recently, InfoTrie reports. InfoTrie rates the sentiment of press coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Ceres earned a news impact score of -1.4 on InfoTrie's scale. They also gave news coverage about the biotechnology company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an effect on the company's share price in the next several days.

What other stocks do shareholders of Ceres own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Ceres investors own include CTI BioPharma (CTIC), Cenveo (CVO), Immunomedics (IMMU), AEterna Zentaris (AEZS), Avid Bioservices (CDMO), SLS International (SLS), Gevo (GEVO), Real Goods Solar (RGSE), Capstone Turbine (CPST) and Palatin Technologies (PTN).

How do I buy shares of Ceres?

Shares of CERE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Ceres' official website?

The official website for Ceres is http://ceres.net/.

How can I contact Ceres?

Ceres' mailing address is 1535 Rancho Conejo Blvd, THOUSAND OAKS, CA 91320-1440, United States. The biotechnology company can be reached via phone at +1-805-3766500.


MarketBeat Community Rating for Ceres (NASDAQ CERE)

Community Ranking:  3.1 out of 5 (star star star)
Outperform Votes:  115 (Vote Outperform)
Underperform Votes:  69 (Vote Underperform)
Total Votes:  184
MarketBeat's community ratings are surveys of what our community members think about Ceres and other stocks. Vote "Outperform" if you believe CERE will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CERE will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 3/26/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel